1 Min Read
Sept 11 (Reuters) - T2 Biosystems Inc
* T2 Biosystems submits 510(K) application to the FDA for review of T2Bacteria Panel Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.